PDSS1
Basic information
Region (hg38): 10:26697701-26746798
Previous symbols: [ "TPRT" ]
Links
Phenotypes
GenCC
Source:
- deafness-encephaloneuropathy-obesity-valvulopathy syndrome (Strong), mode of inheritance: AR
- deafness-encephaloneuropathy-obesity-valvulopathy syndrome (Moderate), mode of inheritance: AR
- deafness-encephaloneuropathy-obesity-valvulopathy syndrome (Supportive), mode of inheritance: AR
- deafness-encephaloneuropathy-obesity-valvulopathy syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Coenzyme Q10 deficiency 2 | AR | Biochemical | There can be a wide range of manifestations, and in some individuals, treatment with Coenzyme Q10 supplementation can be beneficial | Audiologic/Otolaryngologic; Biochemical; Cardiovascular; Endocrine; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Renal | 17332895; 22231380 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (266 variants)
- Deafness-encephaloneuropathy-obesity-valvulopathy_syndrome (101 variants)
- Inborn_genetic_diseases (50 variants)
- not_specified (21 variants)
- PDSS1-related_disorder (6 variants)
- Coenzyme_Q10_deficiency (1 variants)
- Schizophrenia (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDSS1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000014317.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 67 | 70 | ||||
| missense | 139 | 155 | ||||
| nonsense | 8 | |||||
| start loss | 0 | |||||
| frameshift | 12 | |||||
| splice donor/acceptor (+/-2bp) | 1 | |||||
| Total | 6 | 10 | 151 | 77 | 2 |
Highest pathogenic variant AF is 0.00002312916
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PDSS1 | protein_coding | protein_coding | ENST00000376215 | 12 | 49140 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 3.24e-8 | 0.929 | 125704 | 0 | 44 | 125748 | 0.000175 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.32 | 161 | 215 | 0.747 | 0.0000124 | 2674 |
| Missense in Polyphen | 50 | 82.51 | 0.60598 | 1024 | ||
| Synonymous | 0.766 | 69 | 77.6 | 0.889 | 0.00000476 | 809 |
| Loss of Function | 1.85 | 16 | 26.2 | 0.611 | 0.00000177 | 285 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000351 | 0.000351 |
| Ashkenazi Jewish | 0.0000992 | 0.0000992 |
| East Asian | 0.000109 | 0.000109 |
| Finnish | 0.000185 | 0.000185 |
| European (Non-Finnish) | 0.000211 | 0.000211 |
| Middle Eastern | 0.000109 | 0.000109 |
| South Asian | 0.0000653 | 0.0000653 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Supplies decaprenyl diphosphate, the precursor for the side chain of the isoprenoid quinones ubiquinone-10. {ECO:0000269|PubMed:16262699}.;
- Disease
- DISEASE: Coenzyme Q10 deficiency, primary, 2 (COQ10D2) [MIM:614651]: An autosomal recessive multisystem disorder characterized by early-onset deafness, optic atrophy, mild mental retardation, peripheral neuropathy, obesity, livedo reticularis, and cardiac valvulopathy. {ECO:0000269|PubMed:17332895}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Terpenoid backbone biosynthesis - Homo sapiens (human);Metabolism;Ubiquinol biosynthesis;Metabolism of cofactors;Metabolism of vitamins and cofactors;ubiquinol-10 biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.290
Intolerance Scores
- loftool
- 0.385
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58.53
Haploinsufficiency Scores
- pHI
- 0.513
- hipred
- Y
- hipred_score
- 0.527
- ghis
- 0.576
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.136
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pdss1
- Phenotype
Gene ontology
- Biological process
- ubiquinone biosynthetic process;isoprenoid biosynthetic process;protein heterotetramerization
- Cellular component
- mitochondrial matrix;transferase complex
- Molecular function
- trans-hexaprenyltranstransferase activity;metal ion binding;protein heterodimerization activity;trans-octaprenyltranstransferase activity